Skin Cancer

Earlier this week, we shared our third Skin Cancer Awareness Month quiz. Review the answers and your responses below.

The new action date is December 29, 2024.

While MMS is recognized as the gold standard for skin cancer treatment, numerous challenges still hinder widespread adoption and practice.

Andrew Baker, MBA, MPAS, PA-C, discusses his role in skin cancer detection and advice for PAs interested in skin surgeries and Mohs closures.

In recognition of Skin Cancer Awareness Month, Dermatology Times is reviewing research and strides in skin cancer treatment over the last decade.

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month.

Earlier this week, we shared our second Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Researchers say addressing socioeconomic differences may be the key to addressing this disparity.

The analysis revealed a higher rate of discontinuations due to immune-mediated adverse experiences.

Muscle spasms are the most common adverse event experienced by patients treated with hedgehog inhibitors for basal cell carcinomas.

This Skin Cancer Awareness Month, take a look at previous coverage from 2024.

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month.

Earlier this week, we shared our first Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Factors such as ultraviolet radiation, rising temperature, and air pollution may all play a role in the increasing incidence of skin cancers.

This Skin Cancer Awareness Month, we have compiled a list of resources for clinicians to share with their patients.

The awarded grant will span a total of 3 years.

Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.

Researchers found that the diameter of cutaneous melanoma demonstrated a weak positive correlation with tumor thickness.

Dozens of investigators shared findings to advance care in patients with melanoma during Mohs micrographic surgery.

The Harris brothers serve 2 predominantly elderly populations and appreciate the opportunity to provide solutions for the growing complexity of skin cancer issues as patients live longer.

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month and Melanoma Monday.

Robert Den, MD, and Alpha Tau are seeking motivated investigators who may be interested in participating in the trial.

This recap of skin cancer innovations accompanies the cover story of our May publication.

Study findings suggest OCT's effectiveness in accurately diagnosing and mapping BCC, with a high predictive capability for Mohs surgery requirements.

Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.